{"id":1272,"date":"2024-03-23T07:16:30","date_gmt":"2024-03-23T07:16:30","guid":{"rendered":"https:\/\/internationaljournalofmicrobialscience.com\/?page_id=1272"},"modified":"2024-03-23T07:16:30","modified_gmt":"2024-03-23T07:16:30","slug":"references-35","status":"publish","type":"page","link":"https:\/\/internationaljournalofmicrobialscience.com\/index.php\/references-35\/","title":{"rendered":"References"},"content":{"rendered":"

 <\/p>\n

    \n
  1. Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., . . . Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene Reports,22<\/em>, 100997. doi:10.1016\/j.genrep.2020.100997<\/li>\n
  2. Toyoshima, Y., Nemoto, K., Matsumoto, S., Nakamura, Y., &Kiyotani, K. (2020). SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. Journal of Human Genetics,65<\/em>(12), 1075-1082. doi:10.1038\/s10038-020-0808-9<\/li>\n
  3. Aftab, S. O., Ghouri, M. Z., Masood, M. U., Haider, Z., Khan, Z., Ahmad, A., &Munawar, N. (2020). Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach. Journal of Translational Medicine,18<\/em>(1). doi:10.1186\/s12967-020-02439-0<\/li>\n
  4. Ziebuhr, J. (2005). The Coronavirus Replicase. Current Topics in Microbiology and Immunology Coronavirus Replication and Reverse Genetics,<\/em> 57-94. doi:10.1007\/3-540-26765-4_3<\/li>\n
  5. Pachetti, M., Marini, B., Benedetti, F., Giudici, F., Mauro, E., Storici, P., . . .Ippodrino, R. (2020). Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. doi:10.21203\/rs.3.rs-20304\/v1<\/li>\n
  6. Rouchka, E. C., Chariker, J. H., & Chung, D. (2020). Phylogenetic and Variant Analysis of 1,040 SARS-CoV-2 Genomes. doi:10.20944\/preprints202005.0396.v1<\/li>\n
  7. Chen, J., Wang, R., Wang, M. and Wei, G., 2020. Mutations Strengthened SARS-CoV-2 Infectivity. Journal of Molecular Biology<\/em>, 432(19), pp.5212-5226.<\/li>\n
  8. Leung, K., Shum, M. H., Leung, G. M., Lam, T. T., & Wu, J. T. (2021). Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Eurosurveillance,26<\/em>(1). doi:10.2807\/1560-7917.es.2020.26.1.2002106<\/li>\n
  9. Hou, Y. J., Chiba, S., Halfmann, P., Ehre, C., Kuroda, M., Dinnon, K. H., . . . Baric, R. S. (2020). SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science<\/em>. doi:10.1126\/science.abe8499<\/li>\n
  10. Domingo, E. (2010). Mechanisms of viral emergence. Veterinary Research,41<\/em>(6), 38. doi:10.1051\/vetres\/2010010<\/li>\n
  11. P;, S. R. (n.d.). Mechanisms of viral mutation. Retrieved from https:\/\/pubmed.ncbi.nlm.nih.gov\/27392606\/<\/a><\/li>\n
  12. Steinhauer, D. A., Domingo, E., & Holland, J. J. (1992). Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene,122<\/em>(2), 281-288. doi:10.1016\/0378-1119(92)90216-c<\/li>\n
  13. Chitranshi, N., Gupta, V. K., Rajput, R., Godinez, A., Pushpitha, K., Sheng, T., . . . Graham, S. (2020). Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CLPro targeting repurposed drug candidates. doi:10.21203\/rs.3.rs-28084\/v<\/li>\n
  14. Arambaut, Garmstrong, & Isabel. (2020, December 18). Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Retrieved from https:\/\/virological.org\/t\/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations\/563<\/a><\/li>\n
  15. Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012\/01 in England. (2020, December 23). Retrieved from https:\/\/cmmid.github.io\/topics\/covid19\/uk-novel-variant.html<\/a><\/li>\n
  16. SARS-CoV-2 Variant \u2013 United Kingdom of Great Britain and Northern Ireland. (2020, December 24). Retrieved fromhttps:\/\/www.who.int\/csr\/don\/21-december-2020-sars-cov2-variant-united-kingdom\/en<\/a><\/li>\n
  17. Threat Assessment Brief: Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom. (2020, December 20). Retrieved from https:\/\/www.ecdc.europa.eu\/en\/publications-data\/threat-assessment-brief-rapid-increase-sars-cov-2-variant-united-kingdom<\/a><\/li>\n
  18. Starr, T. N., Greaney, A. J., Hilton, S. K., Crawford, K. H., Navarro, M. J., Bowen, J. E., . . . Bloom, J. D. (2020). Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. doi:10.1101\/2020.06.17.157982<\/li>\n
  19. Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y., . . . Zhou, Y. (2020). Rapid adaptation of SARS-CoV-2 in BALB\/c mice: Novel mouse model for vaccine efficacy. doi:10.1101\/2020.05.02.073411<\/li>\n
  20. Peacock, T. P., Goldhill, D. H., Zhou, J., Baillon, L., Frise, R., Swann, O. C., . . . Barclay, W. S. (2020). The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells. doi:10.1101\/2020.09.30.318311<\/li>\n
  21. Kemp, S., Harvey, W., Datir, R., Collier, D., Ferreira, I., Meng, B., . . . Gupta, R. K. (2020). Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion H69\/V70. doi:10.1101\/2020.12.14.422555<\/li>\n
  22. Hoffmann, M., Kleine-Weber, H., &P\u00f6hlmann, S. (2020). A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Molecular Cell,78<\/em>(4). doi:10.1016\/j.molcel.2020.04.022<\/li>\n
  23. England, P. H. (2021, January 15). Investigation of novel SARS-CoV-2 variant: Variant of Concern 202012\/01. Retrieved from <\/u>https:\/\/www.gov.uk\/government\/publications\/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201<\/a><\/li>\n
  24. Paul, D., Jani, K., Kumar, J., Chauhan, R., Seshadri, V., Lal, G., . . .Shouche, Y. S. (2020). Phylogenomic analysis of SARS-CoV-2 genomes from western India reveals unique linked mutations. doi:10.1101\/2020.07.30.228460<\/li>\n
  25. Bhattacharjee, S., & Dhakane, R. (n.d.). Can Coronaviridae Viruses Reappear with their Novel Variants in Upcoming Years. Retrieved from https:\/\/www.academia.edu\/42827731\/Can_Coronaviridae_Viruses_Reappear_with_their_Novel_Variants_in_Upcoming_Years<\/a><\/li>\n
  26. Emerging SARS-CoV-2 Variants. (n.d.). Retrieved from https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/more\/science-and-research\/scientific-brief-emerging-variants.html<\/a><\/li>\n
  27. (2021, January 11). Phylogenetic relationship of SARS-CoV-2 sequences from Amazonas with emerging Brazilian variants harboring mutations E484K and N501Y in the Spike protein. Retrieved from https:\/\/virological.org\/t\/phylogenetic-relationship-of-sars-cov-2-sequences-from-amazonas-with-emerging-brazilian-variants-harboring-mutations-e484k-and-n501y-in-the-spike-protein\/585<\/a><\/li>\n
  28. Wise, J. (2020, December 16). Covid-19: New coronavirus variant is identified in UK. Retrieved from https:\/\/www.bmj.com\/content\/371\/bmj.m4857<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

      Rahman, M. S., Hoque, M. N., Islam, M. R., Islam, I., Mishu, I. D., Rahaman, M. M., . . . Hossain, M. A. (2021). Mutational insights into the envelope protein of SARS-CoV-2. Gene Reports,22, 100997. doi:10.1016\/j.genrep.2020.100997 Toyoshima, Y., Nemoto, K., Matsumoto, S., Nakamura, Y., &Kiyotani, K. (2020). SARS-CoV-2 genomic variations associated with mortality rate […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1272","page","type-page","status-publish","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t